AbstractBackgroundWe investigated whether head and…
AbstractClinical benefit of ALK tyrosine…
AbstractPurpose: Given that osimertinib is th…
AbstractBackground: With the advance of immun…
AbstractAdequate preclinical model and model estab…
AbstractBackground: Immune checkpoint blockad…
AbstractPurpose: Immune checkpoint inhibitors…
AbstractAnaplastic lymphoma kinase (ALK) inhibitor…
AbstractBackground: Preclinical models that c…
AbstractBackground: Anaplastic lymphoma recep…
AbstractProfilin-like protein in Toxoplasma gondii…
AbstractAberrant fibroblast growth factor receptor…
AbstractTo investigate the expression of programme…
AbstractObjectives: The epidermal growth fact…
AbstractThe purpose of this study was to investiga…
